Georgia Capital (LSE:CGEO) Stock Looks Cheap Despite Strong Q3 Earnings

Georgia Capital came into its Q3 2026 earnings with a reputation as a deeply discounted holding company trading on a P/E of 2.7x and a share price of £43.95 at last close. The story investors repeat is simple: a collection of solid Georgian assets supposedly mispriced on the London market.

The fresh numbers tell a sharper story. Net income excluding extra items for Q3 reached GEL 794.2m and basic earnings per share rose to GEL 26.74. The stock has not yet caught up with that headline, which keeps the gap between reported performance and market price firmly in view.

Like the Georgia Capital story but want a broader set of deeply discounted businesses with earnings to back it up? Check out our 10 high quality undervalued stocks as a benchmark list of companies where low P/E ratios meet solid fundamentals.

Q3 2026 Earnings Summary

• Total Revenue (Q3 2026 vs Q3 2025): 55.464 million GEL vs. 113.815 million GEL (directionally lower in Q3 2026)
• Net Income (Excl. Extra Items, Q3 2026 vs Q3 2025): 794.219 million GEL vs. 282.817 million GEL (very large increase in Q3 2026)
• Basic EPS (Q3 2026 vs Q2 2026): 26.74 GEL vs. 23.78 GEL (up 12.5% quarter on quarter)
• Net Profit Margin (Trailing 12 Months vs Prior Year): 99.4% vs. 99.7% (slight margin compression year on year)

Earnings grab attention, but investors who care about valuation usually follow the cash moving through Georgia Capital's portfolio rather than the accounting line at the bottom of the income statement. On Georgia Capital's cash flows alone, the stock could be a hefty 35% undervalued.

Georgia Capital’s Earnings Momentum and Bullish Signals

For anyone backing Georgia Capital as a broad play on Georgian private business, the latest numbers lean supportive. Net income excluding extra items reached GEL 794.2m and basic EPS moved up to GEL 26.74, which fits a story of earnings power rather than accounting noise. Private portfolio revenue grew 18.5% year on year and EBITDA rose 26.3%, with retail pharmacy, healthcare services and insurance all contributing. A fully delevered holding company with record portfolio value around GEL 6.2b points to a cleaner balance sheet and more optionality for capital returns.

Where The Bearish Narrative Still Finds Hooks

Caution around Georgia Capital does not disappear. Top line in Q3 fell to GEL 55.5m from GEL 113.8m, so reported revenue does not move in lockstep with profit. The private equity model and fair value gains mean net income can look strong even when operating revenue trends are mixed. Country and concentration risk also remain, since every asset is tied to Georgia. The share price was down about 7.6% over the past month despite strong quarterly EPS, which suggests some investors still price in those structural concerns.

After fair value gains and non cash items, are you sure these earnings are as clean as they look? Review the full risk analysis for Georgia Capital which shows 2 important warning signs

Hunt For Mispriced Earnings Power

Georgia Capital recently showed that strong earnings and its share price can move out of sync. The real opportunity is to focus on stocks that appear undervalued before any gap in value adjusts.

• Company 1 - 23% below our estimate - turn a record long-cycle defense backlog and autonomous systems work into higher volume programs needing careful execution and scaling.
• Company 2 - 41% below our estimate - shift a private markets platform toward higher fee real asset strategies as fundraising channels and new wealth products expand fee earning assets.
• Company 3 - 30% below our estimate - expand an IT infrastructure franchise by absorbing a concentrated enterprise customer base and integrating larger scale system upgrades into its service model.

Those are three of them. See all 10 potentially undervalued companies →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com